Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age and is strongly associated with insulin resistance and metabolic dysfunction. Preptin is a pancreatic peptide co-secreted with insulin and has been implicated in glucose metabolism and insulin resistance. However, limited data exist regarding serum preptin levels in patients with PCOS.
The aim of this study is to evaluate serum preptin levels in women diagnosed with PCOS and to investigate the relationship between preptin levels and insulin resistance parameters.
Inclusion Criteria:
Exclusion Criteria:
ganataca@yahoo.com+905059284244
Patients diagnosed with PCOS according to the Rotterdam criteria.
Women presenting with similar complaints but not meeting Rotterdam diagnostic criteria for PCOS.
Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients
Metabolic Disturbances in Polycystic Ovary Syndrome (PCOS)
Functional Proteins in Polycystic Ovary Syndrome
Evaluation of MG53 (TRIM72) Levels in Women With Polycystic Ovary Syndrome: An Observational Study
Incretin Effect in PCOS Women
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
Serum Betatrophin Levels in Normal-Weight and Overweight Adolescents With PCOS
Adipokines in Polycystic Ovary Syndrome